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Abstract 
Lipin-1 is a Mg2+-dependent phosphatidic acid phosphatase involved in the de novo 
synthesis of phospholipids and triglycerides. Using macrophages from lipin-1-deficient 
animals and human macrophages deficient in the enzyme, we show in this work that 
this phosphatase acts as a proinflammatory mediator during TLR signaling and during 
the development of in vivo inflammatory processes. After TLR4 stimulation lipin-1 
deficient macrophages showed a decreased production of diacylglycerol, activation of 
mitogen-activated protein kinases and AP-1. Consequently, the generation of 
proinflammatory cytokines like IL-6, IL-12, IL-23, or enzymes like iNOS and COX-2 was 
reduced. Also, animals lacking lipin-1 had a faster recovery from endotoxin 
administration concomitant with a reduced production of harmful molecules in spleen 
and liver. These findings demonstrate an unanticipated role for lipin-1 as a mediator of 
macrophage proinflammatory activation and support a critical link between lipid 
biosynthesis and systemic inflammatory responses. 
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Introduction 
Macrophages are highly plastic phagocytic cells responsible for the maintenance of 
physiological homeostasis due to their ability to clear pathogens and influence the 
behavior of other immune cells (1). They are activated by pathogen associated 
molecular patterns through specific receptors to generate an inflammatory response 
characterized by a cascade of cytokines and molecules that limit ongoing infection or 
tissue damage. Excessive macrophage activation responses, however, can lead to 
acute pathological diseases, best exemplified by sepsis, or chronic disorders such as 
arthritis, asthma, atherosclerosis or diabetes type 2 (1).  
Engagement of Toll-like receptors (TLR), and specifically TLR4, by molecular 
patterns like lipopolysaccharide (LPS) triggers a cascade of signaling events conducted 
by kinases and adaptor proteins that culminates in the phosphorylation and activation 
of the mitogen activated protein kinase (MAPK)4 family of proteins and the family of 
kinases for the NF-kB transcription factor inhibitors IkB (2-4). MAPKs are responsible 
for the phosphorylation and activation of proteins that are part of the transcription 
factor AP-1, while the phosphorylation of IκB inhibitors promotes their proteasomal 
degradation, thereby releasing active NF-κB proteins. AP-1 and NF-κB are involved in 
the transcription of multiple proinflammatory genes including IL-6, IL-12, IL-23, and 
TNF-α (5). 
LPS-stimulated macrophages accumulate triacylglycerol (TAG) molecules, which 
are used to meet the increased demands of energy of these highly active cells (6, 7). 
TAG is formed by acylation of part of the DAG generated via the Kennedy pathway of 
phospholipid synthesis (8). The enzymes that directly generate diacylglycerol (DAG), in 
the Kennedy pathway, display phosphatidic acid phosphatase activity are a family 
known as the lipins (9, 10). We have previously shown that a member of this family of 
enzymes, lipin-1, is expressed in human macrophages, and regulates eicosanoid 
production and size and number of TAG-loaded lipid droplets (11). However, little is 
known about the role of lipin-1 during macrophage activation through TLRs. Questions 
on the possible involvement of lipin-1 on the production of DAG during TLR 
stimulation, the role of lipin-1 during TLR signaling, whether lipin-1 activity modulates 
proinflammatory gene upregulation, and whether lipin-1 influences inflammatory 
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conditions in vivo remain unanswered. Here we have used genetic and omics 
approaches to determine the role of lipin-1 during TLR activation of macrophages. We 
report that lipin-1 contributes positively to macrophage stimulation through TLR4, and 
other TLRs, by impacting on MAPKs and AP-1 activation and as a consequence, on the 
generation of proinflammatory factors during in vitro and in vivo models of 
inflammation. Thus, lipin-1 connects lipid synthesis with macrophage proinflammatory 
activation.      
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Materials and Methods 
Animals  
BALB/cByJ-Lpin1fld/J mice carrying a spontaneous mutation in the Lpin1 gene (fatty 
liver dystrophy, fld) (9, 12) were purchased from The Jackson Laboratory and bred in 
the Service of Animal Research and Welfare of the University of Valladolid. Males and 
females of Lpinfld/+ genotype were bred to generate Lpinfld/fld (hereinafter fld), Lpinfld/+ 
and wild type (wt) sibling animals. Mice were housed in filter-top cages and were 
provided with sterile water and food ad libitum (Global diet 2014, Harlan). 12-Week 
old sex-matched animals were used for experimentation. All the protocols and 
procedures were approved by the Institutional Animal Care and Usage Committee and 
are in accordance with the Spanish and European Union guidelines for the use of 
experimental animals.  
 
Reagents  
LPS from Escherichia coli 0111:B4, 1,2-diheptadecanoyl-sn-glycerol and the antibody 
against β−actin were obtained from Sigma-Aldrich. Antibodies against IκBα, IκBβ, 
phospho-p38 MAPK (Thr180/Tyr182), p38 MAPK, phospho-p44/42 MAPK 
(Thr202/Tyr204), p44/42 MAPK, phospho-SAPK/JNK (Thr183/Tyr185), SAPK/JNK and 
phospho-c-Jun were purchased from Cell Signaling. Antibodies against the nuclear 
protein p84 were from Abcam. Antibodies against iNOS were from BD Biosciences and 
anti-COX-2 from Cayman. The rabbit antiserum against lipin-1 was previously 
described (11). PE-conjugated antibodies against CD11b, APC-conjugated antibodies 
against F4/80, FITC-conjugated antibodies against Gr1 and 7-amino-actinomycin D 
were purchased from ebiosciences. Specific ON-Target plus siRNAs against murine 
mRNAs were obtained from Dharmacon (Thermo Scientific). Silencer® Select siRNAs 
specific to decrease the expression of human lipin-1 mRNA and negative controls were 
purchased from Ambion. 
 
Cells  
To obtain peritoneal macrophages, the peritoneal cavity was flushed twice with 5 ml of 
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ice-cold PBS. Resident cells were centrifuged for 10 min at 300 x g, and allowed to 
adhere to plastic for 18 h in RPMI 1640 medium containing 10% fetal bovine serum. 
Non-adherent cells were washed away, and attached cells were maintained in culture 
until use. 
To obtain bone marrow-derived macrophages (BMDMs), intact femurs and 
tibias were aseptically dislocated from the hind legs of the mice. The marrow was 
flushed with 5 ml of PBS using a 25 g sterile needle. After filtration, bone marrow cells 
were centrifuged for 10 min at 300 x g, cultured and differentiated according to the 
procedure described by Johnson et al. (13). Briefly, the cells were cultured in growth 
medium supplemented with 20% supernatant of the mouse L929 cell (conditioned 
medium) and cultured for 7 days. The medium was changed at day 4, washing out the 
non-adherent cells and differentiation was continued for a total of 7 days.  
Neutrophils were isolated from bone marrow using a Percoll® gradient as 
described (14). T and B lymphocyte populations were isolated from spleen using nylon 
wool columns (15). Briefly, splenocytes were depleted of erythrocytes by ammonium 
chloride-mediated lysis. Cells were then incubated in plastic plates at 37oC and 5%CO2 
for 2 h. Non-adherent cells containing mainly B and T cells were further subjected to 
nylon wool (Polysciences, Inc.) purification, allowing them to adhere to the column at 
37oC and 5%CO2 in RPMI for 1 hour. Non adherent T cells were eluted with warm 
RPMI, and B cells were also collected afterwards by adding cold media, knocking the 
column to dislodge binding cells. The cell surface markers of the resulting populations 
were routinely monitored. 
Human macrophages were obtained from blood monocytes and transfected 
using the nucleofection technique (Amaxa), as previously described (11, 16-18).  
 
Measurement of DAG mass  
A cell extract corresponding to 1 mg of protein was used and, before the extraction 
and separation of lipid classes, 1,2-diheptadecanoyl-sn-glycerol was added as an 
internal standard. Total lipids were extracted according to Bligh and Dyer (19), and the 
resulting lipid extract was separated by thin-layer chromatography using n-
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hexane/diethyl ether/acetic acid (70:30:1, by vol.) as the mobile phase. Spots 
corresponding to the various lipid classes were scraped, and DAG was extracted from 
the silica with 1 ml chloroform/methanol (1:1, v/v) followed by 1 ml of 
chloroform/methanol (2:1, v/v). The DAG fraction was transmethylated with 500 μl of 
0.5 M KOH in methanol for 45 min at 37°C and a volume of 0.5 M HCl was added 
before extracting twice with 1 ml of n-hexane. Analysis of fatty acid methyl esters was 
carried out in a Agilent 7890A gas chromatograph coupled to an Agilent 5975C mass-
selective detector operated in electron impact mode (70 eV) equipped with an Agilent 
7693 autosampler and an Agilent DB23 column (60 m length × 250 μm internal 
diameter × 0.15 μm film thickness) under the conditions established previously (20-
22). The amount of DAG mass in each sample was calculated by adding the molar 
masses of all fatty acids measured and dividing by 2. Data analysis was carried out with 
the Agilent G1701EA MSD Productivity Chemstation software, revision E.02.00. 
 
Real time PCR   
Total RNA from mouse tissues and cells was extracted using RNeasy Mini Kit (Quiagen) 
and Trizol reagent (Ambion) respectively. The cDNA templates were synthesized using 
M-MLW Reverse Transcriptase (Ambion) following the manufacturer instructions.  
Quantitative real time (RT)-PCR analysis was performed in a LightCycler® 480 (Roche) 
as previously described (18) using specific primers obtained from the Primer Bank data 
base (23). 
 
Cytokine determination and serum analysis 
Supernatants from activated cells or serum from LPS-treated animals were used for 
quantification of IL-6, IL12p40, IL2p70 and IL23p19 by specific ELISA kits (eBioscience) 
following the manufacturer’s instructions. Urea, blood urea nitrogen (BUN), creatinine, 
aspartate aminotransferase (AST) and alanine aminotransferase (ALT) measurements 
in serum were kindly performed by Laboratorios Echevarne (Barcelona, Spain). 
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LPS treatment of animals  
Mice were intraperitoneally injected with LPS at a lethal dose of 25 mg/kg or a 
sublethal dose of 1.5 mg/kg and monitored for 10 days. For the analysis of 
proinflammatory factors some animals were sacrificed by ketamine (100 mg/kg): 
xylacine (10 mg/kg) administration and cervical dislocation 6 hours after LPS 
treatment. Blood was collected through cardiac puncture or from the facial vein. Livers 
and spleens were collected in RNAlater (Ambion) for further analysis by real-time PCR.  
 
Microarray gene expression  
Peritoneal macrophages from four different control (Lpinfld/+) and fld (Lpinfld/fld) male 
animals were separately stimulated with 100 ng/ml LPS for 5 h and RNA was isolated 
using Trizol reagent (Ambion). Labeled RNA was hybridized overnight (17 h, 65°C) to 
Agilent Whole Mouse Genome Oligo Microarrays 4x44K using Agilent recommended 
protocol. After extensive washing, fluorescence signals were detected using Agilent 
Microarray Scanner System (Agilent Technologies). The Agilent Feature Extraction 
Software (FES) was used to read out and process the microarray image files and the 
Rosetta Resolver® gene expression data analysis system (Rosetta Biosoftware) was 
used for further analysis. The ratios represent comparisons to a common artificial 
reference in which all untreated samples are included (control and fld). For selection 
genes were required to be at least 1.7-fold change up- or downregulated with an 
associated p-value of 0.01 in relation with the reference. All microarray data have been 
deposited into the Gene Expression Omnibus (GEO) database (accession number 
GSE54155). 
 
Flow cytometry 
Cells from whole spleen or peritoneal lavage were incubated with antibodies against 
CD16/CD32 (eBiosciences) to block nonspecific antibody binding to Fc receptors. Cells 
were then stained with PE-conjugated rat anti-mouse CD11b IgG2b, APC-conjugated 
rat anti-mouse F4/80 IgG2a and FITC-conjugated rat anti-mouse Gr1 IgG2b 
(ebiosciences). Isotype control antibodies were used to subtract background staining. 
Staining with 7-amino-actinomycin D was also performed to exclude nonviable cells 
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during the analysis. Data collection was performed in a Beckman Coulter Gallios flow 
cytometer and data analyses were performed using the Kaluza software. 
 
DNA Binding Assays 
The DNA binding activity of nuclear c-Jun was assayed by a commercial kit (Active 
Motif) following the manufacturer’s instructions.  
 
Constructs and Transfections 
Lipin1β-EGFP plasmid was constructed by introducing the cDNA sequence of the 
mouse Lpin1b (Thermo Scientific, clone 4211202) in the EGFP expression vector 
pEGFP-N3 (Clontech) by using EcoRI and SalI restriction enzymes. The primers used 
were as follows: 5´-CACACAGAATTCAATGAATTACGTGGGGCAGC-3´ and 5´-
CACACAGTCGACAGCTGAGGCTGAATGCATGT-3. Confirmation of the correct insertion of 
the cDNA was performed by sequencing. Plasmids (EGFP or lipin1-EGFP) were 
transfected into BMDMs by using the Nucleofection method, and the kit specifications 
for murine macrophages were followed. 3 µg of plasmid was used and the program 
was Y-001.   
 
Statistical analysis  
Data are represented as means ± standard error of the mean (SEM). Statistical 
significance was determined by Student’s t test. p<0.05 was considered statistically 
significant. 
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Results 
Lipin-1 deficient macrophages have a decreased inflammatory gene expression after 
TLR4 stimulation 
We began this study by analyzing the expression levels of lipin-1 in immune cells and 
tissues. The highest levels of lipin-1 were present in peritoneal macrophages and 
spleen, both at the mRNA and protein levels (Figs. 1A and 1B). The absence of lipin-1 
altered neither the overall percentage of macrophages in peritoneal cells and spleen 
nor the percentage of cells in the blood of fld animals (Supplemental Fig. 1). Next, we 
evaluated whether the expression of  lipin-1 was affected by TLR activation in 
macrophages. Figure 1C shows that although the mRNA levels rapidly decreased within 
the first 4 h after TLR4 activation by LPS, lipin-1 protein levels were still maintained 
after 24 h of treatment.   . Protein levels did not change between 0 and 12 h, nor did 
mRNA levels change between 12 and 24 h.  
To assess whether lipin-1 is involved in macrophage responses to TLR4, 
peritoneal cells from wt and fld animals were stimulated with LPS, and mRNA 
abundance of the proinflammatory factors Il6, Il12b (p40), Nos2 and Cox2 were 
analyzed by quantitative PCR. The results showed that fld macrophages increased the 
mRNA levels for all those factors to a lesser extant than wt macrophages (Fig. 2A). To 
rule out the possibility that the diminished response of fld macrophages to TLR4 
stimulation occurs because of alterations in the in vivo differentiation process due to 
the absence of lipin-1, experiments were also conducted using the macrophage-like 
cell line RAW 264.7. In these cells, lipin-1 was knocked down by siRNA technology. 
Again, the absence of lipin-1 led to reduced responses to LPS (Fig. 2B). A more 
exhaustive analysis in bone marrow-derived macrophages (BMDMs) indicated that 
many inflammation-related genes were affected in fld derived cells, including Il12a 
(p35), Il23a (p19), Tnfa, and Ifng (Fig. 2C). These results were also corroborated by 
analysis of protein levels in the supernantants or cell homogenates of TLR4-activated 
cells (Fig. 2D and E). The observed responses were not due to a lower expression of 
TLR4 in the fld macrophages, as the latter cells expressed TLR4 at levels identical to wt 
cells (data not shown). Also, no differences in macrophage cell surface markers were 
found between wt and fld BMDMs, suggesting no differences in their level of 
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differentiation (Supplemental Fig. 2). Collectively, these results suggest that lipin-1 is 
centrally involved in the inflammatory response to TLR4 occupancy in macrophages. 
 
Lipin-1 deficient macrophages show a distinctive gene expression pattern after TLR4 
stimulation.  
To obtain a broader view of lipin-1 regulated genes during LPS activation, gene 
expression was analyzed by RNA microarrays in BMDMs stimulated with LPS during 5 h 
(Fig. 3).  A total of 1640 genes were upregulated by LPS in control macrophages while 
1519 genes were upregulated in fld cells. Of note, only 943 genes were upregulated in 
both types of cells indicating a qualitative differential response between control and 
fld macrophages to LPS. The same behavior was observed on examination of 
downregulated genes, where only 1009 genes were downregulated in both types of 
cells, while 1044 genes were downregulated exclusively in control macrophages and 
780 genes in fld macrophages. Genes differentially regulated in fld macrophages are 
involved in processes such as receptor signaling, G-protein signaling, transcription, lipid 
metabolism, cell adhesion, and extracellular matrix, among others (Fig. 3 and 
Supplemental Table 1), which indicates that lipin-1 might be relevant not only for the 
proinflammatory response, but also for other processes during the macrophage 
response to pathogens. 
 
Lipin-1 deficient macrophages have altered responses to other TLRs 
To assess whether signaling through other TLRs is also affected in fld macrophages, 
experiments were conducted using the TLR3 ligand poly(I:C) and the TLR1/2 ligand 
Pam3CSK4. Evaluation of the expression of proinflammatory genes showed that mRNA 
levels for Il6 and Il13a were lower in poly(I:C)-stimulated fld macrophages while Nos2 
and Cox2 were not affected (Fig. 4A). Also, fld cells stimulated with Pam3CSK4 
exhibited lower mRNA levels for Il6, Il23a and Nos2 than wt cells (Fig. 4B).  We also 
examined the effects of non classical TLR4 activators such as the saturated fatty acid 
palmitic acid (24). In line with our findings with LPS, the effects of palmitic acid were 
diminished in fld cells (Fig. 4C). Thus, these results suggest that the diminished 
inflammatory response of fld macrophages is not restricted to a particular TLR but 
rather works at a more general level during cell activation. 
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Lipin-1 deficient macrophages exhibit altered TLR4 signaling  
We next evaluated whether TLR4 signaling pathways are affected in lipin-1 deficient 
cells. As illustrated in Fig. 5, fld macrophages responding to LPS showed a reduced 
phosphorylation of the MAPK family members p44/p42 ERKs, JNK and p38 (Fig. 5A, B). 
Of note, phosphorylation and nuclear activity of the downstream protein c-jun, which 
forms part of the transcription factor AP-1, was also diminished in LPS-stimulated 
macrophages from fld mice (Fig. 5C, D). We also examined the degradation of the NF-
κB inhibitors, IκBα and IκBβ in fld macrophages, and found no significant differences 
when compared to wt cells (Fig. 5E). Hence, these data suggest that diminished 
activation of MAPK/AP-1, but not NF-κB, is responsible for the reduced 
proinflammatory behavior observed in fld macrophages. Therefore, not all TLR4-
mediated signaling seems to be affected by lipin-1 depletion, but only the branch that 
is downstream to MAPK activation.  
Because the enzymatic activity of lipin-1 produces DAG, experiments were conducted 
next to evaluate the involvement of lipin-1 in DAG generation during TLR4 activation. 
DAG production by LPS in fld and wt macrophages was analyzed by mass spectrometry. 
In wt macrophages, LPS stimulation promoted a time-dependent increase in total 
cellular DAG mass (Fig. 5F). Importantly, in fld cells the opposite situation occurred, 
and DAG levels not only did not increase but actually decreased after LPS activation, 
thus suggesting that in the absence of lipin-1 the degradation of DAG and/or its 
conversion to other products predominates over its accumulation (Fig. 5F). 
Collectively, these data are consistent with lipin-1 being a major mediator of early DAG 
generation in LPS activated macrophages. 
Experiments were also conducted to assess whether expressing lipin-1 in fld 
macrophages restores the proinflammatory responses of these cells. Fld BMDMs were 
transiently transfected with a plasmid encoding for lipin-1, and ERK-1/2 
phosphorylation and iNOS expression was analyzed by immunoblot. The results, as 
shown in Fig. 6, clearly show that lipin-1 expression restored these two responses.  
Analysis of LPS-stimulated DAG production in the   oreover, transfecting the 
cells with lipin-1 also restored the DAG response to LPS 
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t Thus, transfecting in lipin-1 also restores DAG synthesis and the DAG response to LPS 
 
Lipin-1 deficient mice have a quicker recovery from endotoxin treatment  
To define the in vivo implication of the above findings, the effect of an i.p. 
administration of LPS was evaluated in animals. At high doses of LPS (25 mg/Kg) there 
were not significant differences in mortality rates between wt and fld animals (Fig. 7A). 
However, at lower LPS doses (1.5 mg/Kg), which did not provoke death, fld animals 
had a faster weight recovery than wt animals (Fig. 7B). While fld animals returned to 
their original weight after 6 days of treatment, wt animals needed longer than 10 days 
to recover, suggesting that fld animals resolve the injury faster. Furthermore, analyses 
of urea, BUN, creatinine, AST and ALT in serum from fld versus wt animals showed 
reduced levels in the former, thus suggesting a less pronounced organ damage (Fig. 
7C).   
Analysis of the blood content of proinflammatory cytokines in LPS-treated 
animals showed a substantial decrease in the content IL-6, IL-12p40 and IL-12p70 in fld 
animals compared with control ones (Fig. 8A). A more exhaustive investigation of 
proinflamatory gene expression performed in the liver and the spleen of treated 
animals showed that many of those genes were less up-regulated in fld animals (Fig. 
8B, C). Significantly decreased levels of the proinflammatory protein iNOS, were also 
detected in peritoneal cells of LPS-exposed fld animals (Fig. 8D).  
  At the cellular level, we noticed that animals without treatment showed no 
differences in the percentage of total CD11b+ cells in spleen. However, we found that 
the absence of lipin-1 had opposite effects on splenic CD11+F4/80-Gr1+ and 
CD11b+F480+Gr1+ populations, decreasing the former (neutrophils) and increasing the 
later (inflammatory monocytes) (Fig. 9A). On the other hand, spleens from LPS-treated 
animals showed an increase in CD11b+ cell populations that was significantly higher in 
fld animals (Fig. 9A) than in wt animals. A more detailed analysis showed that the 
behavior of F4/80 and Gr1 expressing cells was very similar in wt and fld animals, 
except for the CD11b+F4/80+Gr1+ cells, whose recruitment was significantly lower in 
the spleens of fld animals (Fig. 9A and Supplemental Fig. 3). Macrophages 
(CD11b+F4/80+Gr1-) decreased their presence in LPS-treated spleens in the same 
manner in wt and fld animals (Fig. 9A and Supplemental Fig. 3). These observations are 
14 
 
in agreement with a reduced recruitment of inflammatory monocytes to the spleen 
during LPS treatment in the absence of lipin-1.  
The recruitment of immune cells to the peritoneal cavity of non-treated and 
LPS-treated animals was also studied and no significant differences were found in the 
total number or type of cells recruited in fld versus wt animals (Fig. 9B and C). Overall 
these results suggest that fld animals experience a reduced proinflammatory response 
during endotoxin treatment that protects them from excessive damage. 
 
Lipin-1 has a proinflammatory role in human macrophages 
To address whether the proinflammatory effects of lipin-1 in murine macrophages also 
occur in human macrophages, experiments were conducted in blood monocyte-
derived human macrophages that were made deficient in lipin-1 by nucleofection of a 
siRNA against lipin-1 (Fig. 10A). We observed that, after LPS-treatment, the increases 
in mRNA levels for IL6, IL12a, IL12b and IL23a in control cells were less prominent in 
the lipin-1 deficient macrophages. These data are in accordance with our previous 
results in mice.  
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Discussion 
The execution of immune responses by macrophages requires an exquisite balance 
between effector and regulatory pathways, and perturbation of this network can result 
in chronic inflammation or persistent infection. Thus it is important to define the 
effectors that positively and negatively modulate these responses to open new 
avenues for the control of inflammation-related conditions. Our studies demonstrate 
that lipin-1 plays a key regulatory role in the generation of proinflammatory factors by 
mediating the activation of downstream pathways during TLRs activation by microbial 
components. This conclusion is supported by in vitro data using primary human and 
murine macrophages and cell lines as well as by in vivo observations obtained from 
LPS-treated mouse models. Our key findings can be summarized as follows: (i) in 
macrophages, lipin-1 mediates responses to LPS treatment, regulates cellular DAG 
levels, and mediates activation of MAPKs and proteins of the transcription factor AP-1 
that ultimately coordinate the expression of proinflammatory genes (Figure 11); (ii) 
mRNA expression microarray analyses suggest that lipin-1 also affects other processes 
like G-protein signaling, transcription, cell adhesion, etc. in TLR4 stimulated 
macrophages; (iii) lipin-1 delays the recovery of animals to endotoxin treatment by 
limiting the expression of detrimental mediators; (iv) the expression levels of lipin-1 
also impact on other TLRs in addition to TLR4, namely TLR3 and TLR1/2; and (v) the 
proinflammatory role of lipin-1 is also detected in human macrophages.  
During LPS stimulation of macrophages there is an increase in intracellular DAG 
content that does not occur in cells lacking lipin-1, suggesting that lipin-1 is a major 
enzyme involved in the short-term generation of DAG in LPS-treated cells. A recent 
exhaustive state-of-the-art lipidomic study performed in RAW 264.7 macrophages has 
also demonstrated increased DAG levels during TLR4 stimulation (6). DAG may serve 
different roles in cells. From a lipid viewpoint, its classical role is to serve as a 
biosynthetic precursor of different species of phospholipids, which are important for 
membrane organization and signaling, and also of TAG, the main energy storage of 
cells. LPS-treated cells display a very robust membrane rearrangement (25, 26), hence 
they require high energy supply to accomplish all the remodeling that activation 
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encompasses, including the upregulation of many genes and proteins. In fact, TAG 
production is increased in activated macrophages (6, 27-29), and its hydrolysis is an 
absolute requirement for efficient ATP supply and macrophage functioning (30). Thus, 
the possibility exists that in the absence of lipin-1 macrophages may not be able to 
meet the necessary energy levels to fulfill all their activation requirements, resulting in 
the whole cell reprograming being altered. In such a scenario, a reduction of the whole 
activated transcriptional program would be expected. However, the wide analysis of 
gene expression performed in fld macrophages indicates that in these macrophages 
the gene transcription footprint is quite different than in wt cells, and is not the result 
of a mere reduction of transcriptional events. On the other hand, the activation of 
transcriptional effectors such as NF-κB does not seem to be altered in the absence of 
lipin-1, and this is a process that also needs ATP for the phosphorylation and 
degradation of the NF-κB inhibitor, IkB. Thus it could be deduced from these data that 
the effects observed for lipin-1 may not necessarily be related with reduced energy 
availability, at least during the early phases of activation.  
From an intracellular signaling viewpoint, DAG may bind and change the 
activation/localization state of many enzymes in the cell (31). Several DAG-activated 
enzymes are known to be required for full downstream responses during LPS 
activation. For example, enzymes from the protein kinase C (PKC) family such as PKCε 
and PKCδ can associate with different adaptor proteins that are recruited to TLR4 (32-
33). Activation of PKCs requires phosphorylation and enhanced levels of DAG, and the 
action of these kinases impacts on TLR4 downstream pathways such as MAPKs 
activation, which ensures full production of inflammatory factors (34). Our studies 
support a scenario whereby lipin-1, by regulating DAG levels and the activation of 
upstream effectors like PKC, regulates TLR4 downstream signaling. In this regard, we 
have previously shown that Mg2+-dependent phosphatidate phosphatase is involved in 
arachidonic acid mobilization, cyclooxygenase expression and eicosanoid formation 
when WISH cells are activated through PKC (35,36) and when macrophages are 
stimulated with lipopolysaccharide (37). Although the mechanisms for these actions 
are not known these results highlight a role for lipin-1 in cell signaling through 
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modulating PA and DAG levels. Studies are being carried out in our laboratory to 
further explore these possibilities. 
Excessive activation of LPS-promoted responses results in sepsis and septic 
shock. These are systemic inflammatory conditions that constitute a major cause of 
morbidity and mortality in hospitalized patients. It is clear that amelioration of the 
exacerbated proinflammatory response would be a good strategy for their treatment. 
The studies presented here suggest that lipin-1 participates in the development of 
these acute conditions. The absence of lipin-1 clearly promotes an earlier recovery of 
animals treated with a low-dose of LPS. The effect seems to be related with a lower 
expression of harmful proinflammatory mediators, which may favor reduced tissue 
damage and shortens healing time. Furthermore, upregulation of enzymes that 
generate key factors for the development of sepsis such as iNOS and COX-2 are also 
decreased in fld animals. In this sense, we have previously reported that in human 
macrophages decreased expression of lipin-1 reduces the activation of group IVA 
cytosolic phospholipase A2, the enzyme that controls the release of arachidonic acid 
from phospholipids (11). Availability of free arachidonic acid is well described to 
constitute a limiting factor for eicosanoid production via various pathways including 
COX-2 (38, 39). Collectively, these results suggest that lipin-1 may impact on sepsis not 
only by regulating the expression of enzymes such as COX-2, but also by impacting on 
the levels of their substrates.  
Due to the diminished inflammatory response of fld animals, a lower death rate 
during treatment with high LPS doses would be expected. However, animals die within 
24 h of treatment and no differences between wt or fld groups are appreciated. It 
should be noted in this regard that recent work has shown that fld mice exhibit cardiac 
dysfunction in vivo (40). Such defect, together with the well-described cardiac 
dysfunction induced by high levels of LPS, could explain why fld mice are not protected 
against high LPS doses (40, 41).  
To conclude, in this work we have unveiled a hitherto unrecognized role for 
lipin-1, an enzyme of lipid metabolism, in macrophage signaling and animal responses 
to bacterial components. The data presented here support the idea that reducing lipin-
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1 levels would limit the inflammatory response and the damage that exacerbated 
responses during TLR activation could produce. Whether targeted modulation of lipin-
1 can provide therapeutic benefits for the control of inflammatory-related conditions 
should be the focus of future research. 
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Figure Legends 
Figure 1. Lipin-1 expression in immune tissues and cells.  (A) mRNA levels from bone 
marrow cells, whole spleen, T cells, B cells, neutrophils and peritoneal macrophages 
were analyzed by qPCR using specific primers for Lpin1 spliced variants Lpin1α and 
Lpin1β. Levels of Lpin1 mRNAs were normalized to GAPDH mRNA abundance. (B) 
Homogenates from tissues and cells as in panel A were analyzed by immunoblot using 
specific antibodies against lipin-1 and β-actin. Peritoneal macrophages from fld mice 
were also included. A representative experiment from three performed is shown. (C) 
BMDMs from wt and fld animals were stimulated with 100 ng/ml LPS for the indicated 
time points and mRNA was extracted and analyzed by qPCR using specific primers that 
recognized both Lpin1α and β. Results were normalized by GAPDH mRNA abundance. 
(D) Homogenates from BMDMs treated or not with 100 ng/ml LPS for 24 h were 
analyzed as in panel B.  Experiments were independently performed three times. Error 
bars represent the SEM.  
 
Figure 2. Lipin-1 mediates production of proinflammatory factors after TLR4 
stimulation of macrophages. (A) mRNA abundance of proinflamatory genes (as 
indicated) in peritoneal macrophages form wt or fld animals treated or not with 100 
ng/ml LPS for 8 h was analyzed by qPCR. mRNA levels were normalized to GAPDH 
mRNA levels. (B) mRNA abundance of the indicated proinflammatory genes in RAW 
264.7 cells treated with control siRNA or siRNA against lpin1 and then with LPS as in  
panel A. (C) BMDM from wt or fld animals were treated with 100 ng/ml LPS for the 
indicated time points and mRNA abundance for the indicated genes was assessed as in 
panel A. (D) Protein levels of the indicated factors were quantified by specific ELISAs in 
BMDM supernatants from wt and fld animals after 24 h of stimulation with 100 ng/ml 
LPS. (E) Analysis by immunoblot of iNOS and COX-2 levels in BMDMs from wt and fld 
mice after stimulation with 100 ng/ml LPS for the indicated time points. Right graphs 
represent relative quantification of iNOS and COX-2 bands respect to β-actin. 
Experiments were independently performed three times in triplicates (n=6). Error bars 
represent the SEM. P-values by Student’s t test are as indicated (*, p <0.05; ** p<0.01). 
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Figure 3. Lipin-1 affects the expression of many genes during TLR4 stimulation of 
macrophages. (A) Microarray analysis of mRNA expression from control (Lpin1fld/+) and 
fld peritoneal macrophages stimulated for 5 hours with 100 ng/ml LPS (n=4). The 100 
genes with the highest difference in expression between control and fld macrophages 
are represented. Table S1 contains a detailed list of genes. To the right, some genes 
have been grouped in families according to their cellular role. (B) Venn diagrams of 
total genes up or down-regulated by LPS in control and fld animals.  
Figure 4. Lipin-1 effects on TLR3 and TLR1/2 activation in macrophages. (A) BMDM 
from wt or fld animals were treated with 50 µg/ml poly (I:C) for the indicated time 
points. mRNA levels for the indicated proinflammatory genes were assessed by qPCR 
and normalized to GAPDH mRNA abundance. (B) BMDMs were stimulated with 1 
µg/ml Pam3CSK4 for the indicated time points and analyzed as in panel A. (C) BMDMs 
were stimulated with 300 µM palmitic acid complexed to albumin (2:1 molar ratio), 
and analyzed as in panel A. Experiments were independently performed three times in 
triplicates (n=6). Error bars represent the SEM. P-values by Student’s t test are as 
indicated (*, p <0.05; ** p<0.01). 
Figure 5. Lipin-1 is involved in TLR4-dependent signaling in macrophages. (A) BMDMs 
from wt or fld animals were stimulated with 100 ng/ml LPS for the indicated periods of 
time. Homogenates were then evaluated for the presence of total and phosphorylated 
MAPKs family members ERKs 1/2 and JNK by Immunoblot. (B) Homogenates from cells 
treated as in panel A were analyzed for total and phosphorylated p38. (C) Nuclear 
extracts from cells treated as in panel A were analyzed for the presence of 
phosphorylated c-Jun by Immunoblot. The nuclear protein p84 was used as loading 
control. Lower graphs in panels A-C represent relative quantification of the 
phosphoproteins against total protein or a loading control. (D) Nuclear extracts from 
cells treated as in panel A were assayed for c-jun activity using a commercially 
available kit. (E) Homogenates from cells treated as in panel A were analyzed for 
expression of the NF-κB inhibitors IKKα and IKKβ by Immunoblot. Lower graphs 
represent relative quantifications against β-actin. Experiments were independently 
performed three times (n=6). (F) Total content of DAG was analyzed by mass 
spectrometry in BMDMs from wt or fld mice treated with 100 ng/ml LPS for the 
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indicated time points. Data are from a representative experiment form four 
independent ones with similar results (n=10).  Error bars represent the SEM. P-values 
by Student’s t test are as indicated (*, p <0.05; ** p<0.01). 
 
Figure 6. Lipin-1 restores LPS-driven responses in fld macrophages. (A) BMDMs from 
wt and fld animals were transfected with plasmids encoding for EGFP as a control or 
Lipin-1β-EGFP. Six hours after transfection the cells were stimulated with 100 ng/ml 
LPS for 30 min (for ERK phosphorylation analysis) or 24 h (for iNOS expression 
analysis). Homogenates were analyzed by immunoblot using specific antibodies against 
ERKs 1/2, iNOS or β-actin. (B) Homogenates used in panel A were also analyzed by 
immunoblot with an antibody against lipin-1, and β-actin was used as a loading 
control. Experiments were independently performed twice. 
  
Figure 7. Lipin-1 delays recovery after endotoxin treatment in mice. (A) Wt and fld 
animals were treated with 25 mg/kg LPS and survival rates were analyzed. Data 
represents two independent experiments (n=7). (B) Weight changes were evaluated in 
wt or fld animals after an i.p. injection of 1.5 mg/Kg LPS at the indicated time points. A 
representative experiment from 5 different ones is shown (n=12). (*, p <0.05; ** 
p<0.01). (C) 24 h after 1.5 mg/Kg LPS administration, serum concentrations of urea, 
BUN, creatinine, AST and ALT were quantified. Discontinuous lines represent basal 
values. Experiments were performed twice (n=9). Error bars represent the SEM. P-
values by Student’s t test are as indicated (*, p <0.05; ** p<0.01). 
 
Figure 8. Lipin-1 contributes to the proinflammatory response that follows endotoxin 
treatment in mice. (A) Analysis by specific ELISAs of proinflamatory factors in the blood 
of wt or fld mice after an i.p. injection of 1.5 mg/Kg LPS for 6 h. (B,C) mRNA levels of 
different proinflammatory genes analyzed by qPCR in livers (B) or spleens (C) form wt  
or fld mice treated as in panel A. mRNA levels were normalized to GAPDH. Experiments 
were independently performed twice (n=4) (D) Peritoneal cell homogenates from 
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animals treated with 1.5 mg/ml for 24 h were analyzed by Immunoblot using 
antibodies against iNOS and β-actin. The graph on the right shows the relative 
quantification of iNOS against β-actin. Responses from three different animals are 
shown. Experiments were repeated three times. Error bars represent the SEM. P-
values by Student’s t test are as indicated (*, p <0.05; ** p<0.01). 
 
Figure 9. Lipin-1 effects on CD11+ cell populations during endotoxin treatment. (A) 
Splenocytes from wt or fld animals treated or not with 1.5 mg/Kg LPS for 24 h (i.p. 
injection) were characterized by flow cytometry using antibodies against CD11, F4/80 
and Gr-1. Gated CD11+ cells were analyzed for F4/80 and Gr-1 expression. (B) Total 
peritoneal cells from mice treated as in panel A were counted and (C) analyzed by flow 
cytometry. Percentage of gated CD11+ cells expressing F4/80 or Gr-1 is shown. 
Experiments were independently performed three times (n=9). Error bars represent 
the SEM. P-values by Student’s t test are as indicated (*, p <0.05; ** p<0.01). 
 
Figure 10. Lipin-1 mediates proinflammatory activation in human macrophages.  Blood 
monocyte-derived macrophages were nucleofected with 20 nM control siRNA or siRNA 
against Lpin1 and stimulated with 100 ng/ml LPS for 8 h. (A) Cellular homogenates 
were analyzed by immunoblot using antibodies against lipin-1 and β-actin. (B) mRNA 
levels were analyzed by qPCR using cyclophilin for normalization. Experiments were 
independently performed three times in triplicate. Error bars represent the SEM. P-
values by Student’s t test are as indicated (*, p <0.05; ** p<0.01). 
 
Figure 11. Lipin-1 impacts on TLR4 signaling pathways.  
